Chimeric antigen receptor-modified NK-92 cells

AU2026226464A1Pending Publication Date: 2026-10-01IMMUNITYBIO INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
AU2026226464
Authority / Receiving Office
AU · AU
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-11-06
Filing Date
2026-09-03
Publication Date
2026-10-01

Smart Images

  • Figure 00000062_0000
    Figure 00000062_0000
  • Figure 00000063_0000
    Figure 00000063_0000
  • Figure 00000063_0001
    Figure 00000063_0001
Patent Text Reader

Abstract

Abstract Provided are NK-92 cells expressing a chimeric antigen receptor (CAR). The CAR can comprise an intracellular domain of FcεRIγ. Also described are methods for treating a patient having or suspected of having a disease that is treatable with NK-92 cells, such as cancer or a viral infection, comprising administering to the patient NK-92CAR cells. This data, for application number 2022283619, is current as of 2024-07-24 00:13 AEST 20 26 22 64 64 03 S ep 2 02 6 A b s t r a c t S e p 2 0 2 6 2 2 6 4 6 4 0 3 2 0 2 6
Need to check novelty before this filing date? Find Prior Art